Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

T cells redirected to EphA2 for the immunotherapy of glioblastoma.

T cells redirected to EphA2 for the immunotherapy of glioblastoma. Mol Ther. 2013 Mar; 21(3):629-37.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.